HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs
SAN FRANCISCO, March 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) investors who suffered significant losses......
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Evolv
SAN FRANCISCO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman is investigating possible misrepresentations concerning Evolv Technologies Holdings, Inc.......